Applicant, as named in the Orange Book
Mirum
Next listed expiry: Ctexli on 21 Feb 2032. 3 products with live protection, 2 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Ctexli NDA 219488 chenodiol | 21 Feb 2032 exclusivity |
| Livmarli NDA 214662 · 2 strengths maralixibat chloride | 26 Oct 2032 patent, carve-out possible |
| Livmarli NDA 219485 · 4 strengths maralixibat chloride | 5 Oct 2043 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.